These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37047562)

  • 1. Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications.
    Gagliardi M; Chiarugi S; De Cesari C; Di Gregorio G; Diodati A; Baroncelli L; Cecchini M; Tonazzini I
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
    Hard SAAA; Shivakumar HN; Redhwan MAM
    Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives.
    Hassan RH; Gad HA; El-Din SB; Shaker DS; Ishak RAH
    Int J Pharm; 2022 Nov; 628():122278. PubMed ID: 36243325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed Mucoadhesive Amphiphilic Polymeric Nanoparticles Cross a Model of Nasal Septum Epithelium in Vitro.
    Schlachet I; Sosnik A
    ACS Appl Mater Interfaces; 2019 Jun; 11(24):21360-21371. PubMed ID: 31124655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 10. A Novel Delivery Method of Cyclovirobuxine D for Brain-Targeting: Chitosan Coated Nanoparticles Loading Cyclovirobuxine D by Intranasal Administration.
    Wei H; Lai S; Wei J; Yang L; Jiang N; Wang Q; Yu Y
    J Nanosci Nanotechnol; 2018 Aug; 18(8):5274-5282. PubMed ID: 29458577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles.
    Baltzley S; Mohammad A; Malkawi AH; Al-Ghananeem AM
    AAPS PharmSciTech; 2014 Dec; 15(6):1598-602. PubMed ID: 25142821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nasal delivery of nanoencapsulated statins - an approach for brain delivery.
    Clementino A; Batger M; Garrastazu G; Pozzoli M; Del Favero E; Rondelli V; Gutfilen B; Barboza T; Sukkar MB; Souza SA; Cantù L; Sonvico F
    Int J Nanomedicine; 2016; 11():6575-6590. PubMed ID: 27994459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Characterization of Chitosan Nanoparticles for Zidovudine Nasal Delivery.
    Barbi Mda S; Carvalho FC; Kiill CP; Barud Hda S; Santagneli SH; Ribeiro SJ; Gremião MP
    J Nanosci Nanotechnol; 2015 Jan; 15(1):865-74. PubMed ID: 26328451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
    Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
    Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Stability and Mucoadhesive Properties of Chitosan Nanoparticles by Surface Modification with Sodium Alginate and Polyethylene Glycol for Potential Oral Mucosa Vaccine Delivery.
    Amin MK; Boateng JS
    Mar Drugs; 2022 Feb; 20(3):. PubMed ID: 35323455
    [No Abstract]   [Full Text] [Related]  

  • 17. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A; Khan S; Yeole P
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer's disease in intracerebroventricular streptozotocin model for brain delivery.
    Zameer S; Ali J; Vohora D; Najmi AK; Akhtar M
    J Drug Target; 2021 Feb; 29(2):199-216. PubMed ID: 32876502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V; Kaur G
    Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery.
    Jain AK; Chalasani KB; Khar RK; Ahmed FJ; Diwan PV
    J Drug Target; 2007 Jul; 15(6):417-27. PubMed ID: 17613660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.